LJUBLJANA (Slovenia), March 21 (SeeNews) – Slovenian pharmaceuticals producer Krka [LJE:KRKG] recorded a consolidated net profit of 174 million euro ($197.8 million) in 2018, up 14% on the year, the company said on Thursday, citing unaudited data.
Consolidated revenue increased to 1.33 billion euro from 1.27 billion euro in 2017, Krka said in a bourse filing.
Krka's consolidated EBITDA amounted to 343.3 million euro at the end of December, up 12% year-on-year, while its EBIT increased 17% to 232.7 million euro.
The Krka Group allocated 96.3 million euro to investments last year, of which 78.0 million euro to the controlling company.
The group employed 11,390 people at the end of 2018, up 5% year-on-year.
($ = 0.87953 euro)
KRKA d.d. is among the biggest companies in SEE. You can download our SEE Top 100 ranking
here or subscribe to our free Top 100 newsletter
here